Background:
Adults with neurological or cerebrovascular (NeCVD) disease have an elevated risk of influenza-related complications. Whether HD-IIV provides greater relative benefit over SD-IIV in this population is uncertain.
Objective:
To evaluate the relative vaccine effectiveness (rVE) of high-dose inactivate...
M. Yafasov, N. Johansen, D. Modin et al.· Circulation· 0 citations
Early detection of congestion among adults with heart failure and preserved ejection fraction (HFpEF) is critical to optimize therapy prior to overt decompensation, yet traditional tools are insensitive. We sought to examine the association between B-lines on lung ultrasound (LUS) in ambulatory adults with HFpEF...
Elke Platz, K. McDowell, Deepak K. Gupta et al.· European Heart Journal Open· 0 citations
BACKGROUND
Respiratory syncytial virus (RSV) is an important cause of severe respiratory disease in adults, with the highest burden among older adults and individuals with chronic health conditions. The bivalent RSV prefusion F (RSVpreF) vaccine has been shown to prevent RSV-associated respiratory illness, but data fro...
M. Lassen, S. Christensen, M. Yafasov et al.· NEJM Evidence· 1 citation
BACKGROUND
Frailty is a major risk factor for influenza-related complications and can influence vaccine effectiveness. We aimed to assess the relative vaccine effectiveness (rVE) of high-dose (HD-IIV) versus standard-dose inactivated influenza vaccine (SD-IIV) in older adults aged 65 years or older according to frailty...
C. Espersen, N. Johansen, D. Modin et al.· The Lancet Healthy Longevity· 0 citations
In adults aged 60 years or older, RSVpreF vaccination reduced hospitalisations for RSV-related respiratory tract disease with no statistical evidence of effect modification by immunosuppression status; however, the study was not powered to exclude subgroup differences.
A. Reimer Jensen, M. H. Højbjerg Lassen, N. Johansen et al.· The Lancet Healthy Longevity· 0 citations
BACKGROUND
Patients with chronic kidney disease (CKD) and type 2 diabetes (T2D) face high but modifiable risks of incident heart failure (HF). We aimed to ascertain whether the HFpEF-ABA score, a simple 3-variable tool to facilitate timely diagnosis of HFpEF, is associated with adverse cardiovascular (CV) outcomes in p...
R. Inciardi, J. Ostrominski, B. Claggett et al.· Journal of Cardiac Failure· 0 citations
BACKGROUND
Atrial fibrillation (AF) is the most common arrhythmia in dilated cardiomyopathy (DCM) and is associated with adverse outcomes. However, the genetic determinants of AF risk and its prognostic significance across genotyped DCM subtypes remain unknown.
METHODS
In this observational cohort study, we analyzed...
I. Balakrishnan, A. Heymans, B. Claggett et al.· Circulation: Heart Failure· 0 citations
A prediction model is developed to estimate the short-term treatment effects of combination medical therapy on systolic blood pressure (SBP), diastolic BP, estimated glomerular filtration rate (eGFR) and serum potassium and individualized estimates of the expected treatment effect are provided.
Nelson Wang, B. Claggett, M. Pfeffer et al.· Nature Medicine· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.